Medicinal – Page 2

Exploring the Therapeutic Potential of Ganoderma lucidum in Cancer

mycolabadmin

Ganoderma lucidum, a mushroom used in traditional medicine for thousands of years, shows promise in fighting certain blood cancers like leukemia and lymphoma. The mushroom contains special compounds that can kill cancer cells in multiple ways—by triggering cancer cell death, boosting the immune system, and preventing cancer cell growth. While laboratory studies are very encouraging, more testing in humans is needed before it can be used as a standard cancer treatment.

If psychedelics heal, how do they do it?

mycolabadmin

Psychedelic drugs like MDMA and magic mushrooms are showing remarkable promise in treating serious mental health conditions like PTSD and depression, with clinical trials demonstrating higher success rates than traditional therapy alone. However, scientists still don’t fully understand how these drugs work at the molecular and brain level, or whether the hallucinations they produce are necessary for healing. Researchers are investigating whether modified versions without hallucinations could provide the same benefits while being easier to administer, while also exploring how individual factors and treatment environment affect outcomes.

Targeting Polycystic Ovary Syndrome (PCOS) Pathophysiology with Flavonoids: From Adipokine–Cytokine Crosstalk to Insulin Resistance and Reproductive Dysfunctions

mycolabadmin

Polycystic ovary syndrome (PCOS) is a common hormonal disorder affecting millions of women that causes irregular periods, infertility, and metabolic problems. Flavonoids are beneficial plant compounds found in fruits, vegetables, and tea that show promise in treating PCOS by improving insulin sensitivity, reducing inflammation, and balancing hormones. While current medications have limited benefits and side effects, flavonoid supplements could offer a safer, natural way to address multiple PCOS problems simultaneously. However, more large-scale clinical studies are needed to confirm their effectiveness and establish optimal dosing.

Lysergic Acid Diethylamide (LSD) and the Heart: Exploring the Potential Impacts of LSD on Cardiovascular Function

mycolabadmin

This review examines how LSD affects the heart and blood vessels. While some evidence suggests LSD might protect against heart disease by reducing inflammation and blood clots, acute use can dangerously raise heart rate and blood pressure, and cause blood vessel constriction. Regular low-dose use raises concerns about potential valve damage. More research is needed to understand the full cardiovascular safety of LSD before it can be considered for medical use.

Medicinal Mushrooms: Bioactive Compounds, Use, and Clinical Trials

mycolabadmin

This comprehensive review examines how medicinal mushrooms contain natural compounds that can boost immune function, fight cancer cells, reduce inflammation, and protect nerve cells. Different mushroom species like reishi, shiitake, and maitake contain various active substances such as beta-glucans and triterpenes that work through multiple biological pathways. While laboratory and animal studies show promising results, more human clinical trials are needed to confirm effectiveness and establish safe dosing guidelines.

Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat

mycolabadmin

Researchers studied how psilocybin mushrooms given in a retreat setting could help military veterans with traumatic brain injuries who also experienced mental health problems like PTSD and depression. Veterans participated in guided psilocybin ceremonies and showed significant improvements in depression, anxiety, and overall quality of life, along with positive changes in their brain activity patterns measured by EEG. The study suggests that psilocybin retreats may be a promising therapeutic approach for this vulnerable population and supports the need for larger research studies.

Associations Between Escitalopram and Psilocybin Therapy and Brain Resting-State Functional Connectivity in Major Depressive Disorder

mycolabadmin

This study compared how two depression treatments—a common antidepressant called escitalopram and psilocybin therapy—affect brain connectivity and depression symptoms. Both treatments reduced feelings of lacking pleasure and impulsive behaviors in depressed patients. The research found that while both worked, they affected different parts of the brain’s reward system in distinct ways, suggesting they may work through different mechanisms.

New perspective on sustained antidepressant effect: focus on neurexins regulating synaptic plasticity

mycolabadmin

This review explores how hallucinogens like ketamine and psilocybin produce long-lasting antidepressant effects by changing how brain cells communicate. The key mechanism involves special molecules called neurexins that sit at the connections between neurons and control whether those connections strengthen or weaken. By understanding and potentially targeting neurexins, scientists hope to develop new depression treatments that work longer and more effectively than current medications.

Microbiota-based interventions for autism spectrum disorder: a systematic review of efficacy and clinical potential

mycolabadmin

This comprehensive review examines how modifications to gut bacteria through probiotics, prebiotics, synbiotics, and fecal transplants can help children with autism. The research found that while all these treatments showed some promise, fecal microbiota transplantation (FMT) produced the most consistent improvements in both autism-related behaviors and digestive symptoms. These microbiota-based approaches work through the gut-brain connection and were generally safe, making them potentially valuable additions to autism management strategies.

Function of Transcription Factors PoMYB12, PoMYB15, and PoMYB20 in Heat Stress and Growth of Pleurotus ostreatus

mycolabadmin

This research explores how specific genes in oyster mushrooms help them survive and grow better when exposed to heat stress. Scientists created mutant mushroom strains by either increasing or decreasing expression of three genes called PoMYB12, PoMYB15, and PoMYB20. They found that boosting PoMYB12 and PoMYB20 made mushrooms more heat-resistant and grow faster, while reducing PoMYB15 had similar beneficial effects. These discoveries could help farmers grow better oyster mushrooms during hot summer months when heat damage is a major problem.

Research Topic: Medicinal